ARROW THERAPEUTICS LIMITED

Active Cambridge

Other business support service activities n.e.c.

0 employees website.com
Life sciences and medical technology Other business support service activities n.e.c.
A

ARROW THERAPEUTICS LIMITED

Other business support service activities n.e.c.

Founded 8 Apr 1998 Active Cambridge, United Kingdom 0 employees website.com
Life sciences and medical technology Other business support service activities n.e.c.

Previous Company Names

GAC NO.111 LIMITED 8 Apr 1998 — 1 May 1998
Accounts Submitted 22 Apr 2025 Next due 30 Sept 2026 5 months remaining
Confirmation Submitted 11 Apr 2025 Next due 22 Apr 2026 7 days overdue
Net assets £38 £0 2024 year on year
Total assets £38 £0 2024 year on year
Total Liabilities £0
Charges 3
3 satisfied

Contact & Details

Contact

Registered Address

1 Francis Crick Avenue Cambridge Biomedical Campus Cambridge CB2 0AA United Kingdom

Website

www.example.com

Full company profile for ARROW THERAPEUTICS LIMITED (03542871), an active life sciences and medical technology company based in Cambridge, United Kingdom. Incorporated 8 Apr 1998. Other business support service activities n.e.c.. View financials, directors, shareholders, and filings.

Business Summary

This company specializes in providing innovative solutions and services across multiple sectors.

Products & Services

consulting software analytics integration

Reports

Credit Report

In-depth credit score, financial analysis, risk assessment and company intelligence.

Financials

Financials

Period 1 Jan → 31 Dec 2024
Type Total Exemption Full
Next accounts 31 December 2025
Due by 30 September 2026 9 months

Net Assets, Total Assets & Total Liabilities (2014–2024)

Cash in Bank

N/A

Net Assets

£38.00

Total Liabilities

N/A

Turnover

N/A

Employees

N/A

Debt Ratio

N/A

Financial History

Revenue, profit, EBITDA and key financial figures

2024
Dec Year End
2023
Dec Year End
P&L
Revenue
£142.3M
£128.7M
Gross Profit
£48.2M
£43.1M
Operating Profit
£22.4M
£19.8M
Net Profit
£18.1M
£15.9M
EBITDA
£31.5M
£28.2M
Assets
Cash
£24.7M
£21.3M
Total Assets
£89.4M
£82.1M
Liabilities
Total Liabilities
£45.2M
£41.8M
Key Metrics
Employees
1,247
1,156
Latest Revenue
£142.3M
Latest EBITDA
£31.5M
Cash Position
£24.7M

Funding

Fundraising & Grants

Funding Rounds 5

Investors (8)

Investor NameInvestor SinceParticipating Rounds
Investor 1Jan 1999Series B, Seed, Series A
Investor 4Jan 1999Series B, Seed
Investor 5Jan 1999Series B, Seed

Share Capital

Share Capital

Share allotments and capital structure

1 Allotment 10 Shares £50.25m Total
Date FromShare ClassShares AllottedAmount RaisedPrice/Share
20 Nov 201310£50.25m£5.02m

Officers

Officers

0 active 3 resigned
Status

No officers found

No officers found

Shareholders

Shareholders (1)

Astrazeneca Uk Limited
100.0%

Persons with Significant Control

Persons with Significant Control (1)

1 Active

Astrazeneca Uk Limited

United Kingdom

Active
Notified 6 Apr 2016
Nature of Control
  • Ownership Of Shares 75 To 100 Percent,voting Rights 75 To 100 Percent,right To Appoint And Remove Directors

Group Structure

Group Structure

ARROW THERAPEUTICS LIMITED Current Company

Charges

Charges

3 satisfied

Properties

Properties

0 total

No related properties

Documents

Company Filings

DateCategoryDescriptionDocument
7 Oct 2025GazetteGazette Notice Voluntary
24 Sept 2025DissolutionDissolution Application Strike Off Company
2 May 2025OfficersAppointment of Hannah Victoria Tattersall as director on 1 May 2025
1 May 2025OfficersTermination of Adrian Charles Noel Kemp as director on 1 May 2025
22 Apr 2025AccountsAnnual accounts made up to 31 Dec 2024
7 Oct 2025 Gazette

Gazette Notice Voluntary

24 Sept 2025 Dissolution

Dissolution Application Strike Off Company

2 May 2025 Officers

Appointment of Hannah Victoria Tattersall as director on 1 May 2025

1 May 2025 Officers

Termination of Adrian Charles Noel Kemp as director on 1 May 2025

22 Apr 2025 Accounts

Annual accounts made up to 31 Dec 2024

Recent Activity

Latest Activity

Gazette Notice Voluntary

6 months ago on 7 Oct 2025

Dissolution Application Strike Off Company

7 months ago on 24 Sept 2025

Appointment of Hannah Victoria Tattersall as director on 1 May 2025

12 months ago on 2 May 2025

Termination of Adrian Charles Noel Kemp as director on 1 May 2025

12 months ago on 1 May 2025

Annual accounts made up to 31 Dec 2024

1 years ago on 22 Apr 2025